133 related articles for article (PubMed ID: 25856237)
1. Metabolomics analysis and biomarker identification for brains of rats exposed subchronically to the mixtures of low-dose cadmium and chlorpyrifos.
Xu MY; Sun YJ; Wang P; Xu HY; Chen LP; Zhu L; Wu YJ
Chem Res Toxicol; 2015 Jun; 28(6):1216-23. PubMed ID: 25856237
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic analysis for combined hepatotoxicity of chlorpyrifos and cadmium in rats.
Xu MY; Wang P; Sun YJ; Wu YJ
Toxicology; 2017 Jun; 384():50-58. PubMed ID: 28433638
[TBL] [Abstract][Full Text] [Related]
3. Disruption of Kidney Metabolism in Rats after Subchronic Combined Exposure to Low-Dose Cadmium and Chlorpyrifos.
Xu MY; Wang P; Sun YJ; Wu YJ
Chem Res Toxicol; 2019 Jan; 32(1):122-129. PubMed ID: 30500169
[TBL] [Abstract][Full Text] [Related]
4. Identification of metabolite biomarkers in serum of rats exposed to chlorpyrifos and cadmium.
Xu MY; Wang P; Sun YJ; Yang L; Wu YJ
Sci Rep; 2020 Mar; 10(1):4999. PubMed ID: 32193438
[TBL] [Abstract][Full Text] [Related]
5. Joint toxicity of chlorpyrifos and cadmium on the oxidative stress and mitochondrial damage in neuronal cells.
Xu MY; Wang P; Sun YJ; Yang L; Wu YJ
Food Chem Toxicol; 2017 May; 103():246-252. PubMed ID: 28286310
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic biomarkers in urine of rats following long-term low-dose exposure of cadmium and/or chlorpyrifos.
Xu MY; Sun YJ; Wang P; Yang L; Wu YJ
Ecotoxicol Environ Saf; 2020 Jun; 195():110467. PubMed ID: 32182532
[TBL] [Abstract][Full Text] [Related]
7. Synergistic hepatotoxicity by cadmium and chlorpyrifos: disordered hepatic lipid homeostasis.
He W; Guo W; Qian Y; Zhang S; Ren D; Liu S
Mol Med Rep; 2015 Jul; 12(1):303-8. PubMed ID: 25707953
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic interaction for a binary mixture of chlorpyrifos and diazinon in the rat.
Timchalk C; Poet TS; Hinman MN; Busby AL; Kousba AA
Toxicol Appl Pharmacol; 2005 May; 205(1):31-42. PubMed ID: 15885262
[TBL] [Abstract][Full Text] [Related]
9. In vivo interaction between chlorpyrifos and parathion in adult rats: sequence of administration can markedly influence toxic outcome.
Karanth S; Olivier K; Liu J; Pope C
Toxicol Appl Pharmacol; 2001 Dec; 177(3):247-55. PubMed ID: 11749124
[TBL] [Abstract][Full Text] [Related]
10. Impact of repeated nicotine and alcohol coexposure on in vitro and in vivo chlorpyrifos dosimetry and cholinesterase inhibition.
Lee S; Poet TS; Smith JN; Hjerpe AL; Gunawan R; Timchalk C
J Toxicol Environ Health A; 2011; 74(20):1334-50. PubMed ID: 21899407
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos.
Timchalk C; Poet TS; Kousba AA
Toxicology; 2006 Mar; 220(1):13-25. PubMed ID: 16343727
[TBL] [Abstract][Full Text] [Related]
12. Cadmium and chlorpyrifos inhibit cellular immune response in spleen of rats.
Wang P; Wang J; Sun YJ; Yang L; Wu YJ
Environ Toxicol; 2017 Jul; 32(7):1927-1936. PubMed ID: 28296077
[TBL] [Abstract][Full Text] [Related]
13. The effect of route, vehicle, and divided doses on the pharmacokinetics of chlorpyrifos and its metabolite trichloropyridinol in neonatal Sprague-Dawley rats.
Marty MS; Domoradzki JY; Hansen SC; Timchalk C; Bartels MJ; Mattsson JL
Toxicol Sci; 2007 Dec; 100(2):360-73. PubMed ID: 17928393
[TBL] [Abstract][Full Text] [Related]
14. Cholinesterase inhibition and toxicokinetics in immature and adult rats after acute or repeated exposures to chlorpyrifos or chlorpyrifos-oxon.
Marty MS; Andrus AK; Bell MP; Passage JK; Perala AW; Brzak KA; Bartels MJ; Beck MJ; Juberg DR
Regul Toxicol Pharmacol; 2012 Jul; 63(2):209-24. PubMed ID: 22504667
[TBL] [Abstract][Full Text] [Related]
15. Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat.
Smith JN; Campbell JA; Busby-Hjerpe AL; Lee S; Poet TS; Barr DB; Timchalk C
Toxicology; 2009 Jun; 261(1-2):47-58. PubMed ID: 19397948
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterase inhibition and alterations of hepatic metabolism by oral acute and repeated chlorpyrifos administration to mice.
Cometa MF; Buratti FM; Fortuna S; Lorenzini P; Volpe MT; Parisi L; Testai E; Meneguz A
Toxicology; 2007 May; 234(1-2):90-102. PubMed ID: 17382447
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical effects of chronic dietary and repeated high-level acute exposure to chlorpyrifos in rats.
Padilla S; Marshall RS; Hunter DL; Oxendine S; Moser VC; Southerland SB; Mailman RB
Toxicol Sci; 2005 Nov; 88(1):161-71. PubMed ID: 16081522
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profiles of serum from rats after subchronic exposure to chlorpyrifos and carbaryl.
Wang HP; Liang YJ; Long DX; Chen JX; Hou WY; Wu YJ
Chem Res Toxicol; 2009 Jun; 22(6):1026-33. PubMed ID: 19522548
[TBL] [Abstract][Full Text] [Related]
19. Critical periods for the role of oxidative stress in the developmental neurotoxicity of chlorpyrifos and terbutaline, alone or in combination.
Slotkin TA; Oliver CA; Seidler FJ
Brain Res Dev Brain Res; 2005 Jun; 157(2):172-80. PubMed ID: 15963356
[TBL] [Abstract][Full Text] [Related]
20. Repeated exposure to chlorpyrifos alters the performance of adolescent male rats in animal models of depression and anxiety.
Chen WQ; Yuan L; Xue R; Li YF; Su RB; Zhang YZ; Li J
Neurotoxicology; 2011 Aug; 32(4):355-61. PubMed ID: 21453723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
